| Name | butanedioic acid,4-N-[2,6-dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]quinolin-8-yl]pentane-1,4-diamine |
|---|---|
| Synonyms |
Tafenoquine succinate
UNII-DL5J0B8VSS Tafenoquine Succinate tafenoquine maleate Etaquine Tafenoquine (Succinate) |
| Description | Tafenoquine Succinate (WR 238605 Succinate) is an 8-aminoquinoline. Tafenoquine is an anti-malarial prophylactic agent[1]. |
|---|---|
| Related Catalog | |
| Target |
Anti-malarial[1] |
| In Vivo | Tafenoquine exhibits no anti-malarial activity in CYP 2D knock-out mice when dosed at their ED100 values (3 mg/kg) established in WT mice. Tafenoquine anti-malarial activity is partially restored in humanized/CYP 2D6 knock-in mice when tested at two times its ED100 (6 mg/kg)[1]. |
| References |
| Density | 1.237g/cm3 |
|---|---|
| Boiling Point | 565.6ºC at 760mmHg |
| Molecular Formula | C28H34F3N3O7 |
| Molecular Weight | 581.58100 |
| Flash Point | 295.9ºC |
| Exact Mass | 581.23500 |
| PSA | 153.23000 |
| LogP | 6.61990 |
| Storage condition | 2-8℃ |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| RIDADR | NONH for all modes of transport |
|---|